Status:
COMPLETED
Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis
Lead Sponsor:
Bayside Health
Conditions:
Portal Hypertension
Eligibility:
All Genders
18-70 years
Brief Summary
Investigate vasoactive medicators in portal hypertension on stored sera
Eligibility Criteria
Inclusion
- portal hypertension
Exclusion
- Nil
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00163631
Last Update
October 4 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3181